热门出版物 - 学术资源搜索

h5 指数:43
h5 中位数:64

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#12 Developmental Biology & Embryology

标题/作者	引用次数	年份
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement H Ulrich, MM Pillat Stem Cell Reviews and Reports 16 (3), 434-440	435	2020
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future A Golchin, E Seyedjafari, A Ardeshirylajimi Stem Cell Reviews and Reports 16, 427-433	350	2020
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications G Liu, BT David, M Trawczynski, RG Fessler Stem Cell Reviews and Reports 16, 3-32	313	2020
Gelatin Methacrylate (GelMA)-Based Hydrogels for Cell Transplantation: an Effective Strategy for Tissue Engineering S Xiao, T Zhao, J Wang, C Wang, J Du, L Ying, J Lin, C Zhang, W Hu, ... Stem Cell Reviews and Reports 15, 664-679	183	2019
Cell Cycle Regulation of Stem Cells by MicroRNAs MMJ Mens, M Ghanbari Stem Cell Reviews and Reports 14, 309-322	181	2018
Dysfunction of Mesenchymal Stem Cells Isolated from Metabolic Syndrome and Type 2 Diabetic Patients as Result of Oxidative Stress and Autophagy may Limit Their Potential Therapeutic Use K Kornicka, J Houston, K Marycz Stem Cell Reviews and Reports 14, 337-345	144	2018
Biological Products: Cellular Therapy and FDA Approved Products A Golchin, TZ Farahany Stem Cell Reviews and Reports 15 (2), 166-175	134	2019
Is COVID-19 a New Hematologic Disease? B Debuc, DM Smadja Stem Cell Reviews and Reports 17 (1), 4-8	131	2021
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome MZ Ratajczak, K Bujko, A Ciechanowicz, K Sielatycka, M Cymer, ... Stem Cell Reviews and Reports 17, 266-277	128	2021
Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9 R Ben Jehuda, Y Shemer, O Binah Stem Cell Reviews and Reports 14, 323-336	127	2018
Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton’s Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity S Sharif, MH Ghahremani, M Soleimani Stem Cell Reviews and Reports 14, 236-246	97	2018
Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review Z Fazeli, A Abedindo, MD Omrani, SMH Ghaderian Stem Cell Reviews and Reports 14, 1-12	97	2018
Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19 Pinky, S Gupta, V Krishnakumar, Y Sharma, AK Dinda, S Mohanty Stem Cell Reviews and Reports 17 (1), 33-43	91	2021
Mesenchymal Stem Cells on Horizon: A New Arsenal of Therapeutic Agents Z Abbasi-Malati, AM Roushandeh, Y Kuwahara, MH Roudkenar Stem Cell Reviews and Reports 14, 484-499	87	2018
circRNA Expression Profiles in Human Bone Marrow Stem Cells Undergoing Osteoblast Differentiation M Zhang, L Jia, Y Zheng Stem Cell Reviews and Reports 15, 126-138	85	2019
Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects AK Yadav, NS Desai Stem Cell Reviews and Reports 15, 331-355	84	2019
Solid Tumors Challenges and New Insights of CAR T Cell Engineering S Tahmasebi, R Elahi, A Esmaeilzadeh Stem Cell Reviews and Reports 15, 619-636	70	2019
Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects R Singh, O Cuzzani, F Binette, H Sternberg, MD West, IO Nasonkin Stem Cell Reviews and Reports 14, 463-483	69	2018
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises A Basiri, Z Pazhouhnia, N Beheshtizadeh, M Hoseinpour, A Saghazadeh, ... Stem Cell Reviews and Reports 17, 163-175	68	2021
Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility A Golchin Stem Cell Reviews and Reports 17, 56-62	67	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。